Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Nivolumab 240 MG
Locations
5
United States
Moffitt Cancer Center
Tampa, Florida, United States
Washington University School of Medicine
St Louis, Missouri, United States
University of Nebraska
Omaha, Nebraska, United States
Roswell Park Cancer Center
Buffalo, New York, United States
Weill Cornell Medicine
New York, New York, United States
Start Date
July 22, 2019
Primary Completion Date
June 11, 2025
Completion Date
June 1, 2026
Last Updated
June 24, 2025
NCT05733689
NCT07282912
NCT07176312
NCT06529822
NCT06245356
NCT04662710
Lead Sponsor
Weill Medical College of Cornell University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions